A
Ardais Corporation
Ardais Corporation, a leading clinical genomics company, is dedicated to enhancing and accelerating biomedical research
About Ardais Corporation
Ardais Corporation is the company behind RustDesk, an open-source remote desktop software. The software allows users to access and control their computers remotely, and it is available for various operating systems, including Windows and Linux.
RustDesk's business model is centered around its open-source nature, which allows users to self-host the software on their own servers. This provides a higher level of security and control compared to commercial remote desktop solutions. The company also offers a commercial version of the software with additional features and support for enterprise users.
The company's target market includes individuals and businesses that require a secure and customizable remote desktop solution. RustDesk's open-source nature and self-hosting capabilities make it an attractive option for users who are concerned about privacy and data security.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Employees
- 3
- Open positions
- None listed
- Dealroom signal
- 58.1/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotechnology, DNA, Genetics and genomics, Genome Engineering, Arts & Culture, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Mar 2005 | $0 | — | CytomX Therapeutics | — |
| SERIES COther financing | Jan 2003 | $14M | $56M | The Kaufmann Fund · Bessemer Venture Partners · Advanced Technology Ventures · Bioventures Investors | — |
Growth signals
Latest recorded traffic for Ardais Corporation is 0 monthly website visits. Ardais Corporation's team declined 25% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Ardais Corporation in the Lexington ecosystem
The Ardais Corporation office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- AVAdvanced Technology Ventures
CIT Group- EPEGS Healthcare Capital Partners
The Kaufmann Fund
Series B and later3 investors entered at this stage
Bessemer Venture Partners
Advent International- BIBioventures Investors
Other known investors1 additional known investor
CytomX Therapeutics
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ardais Corporation on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ardais Corporation’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







